Carl Hull is a proven industry leader, with over 30 years of experience in the diagnostics and life sciences industries. Having spent 14 years at Abbott Laboratories in a variety of sales, marketing and general management positions, Carl then took on leadership roles at Ventana Medical Systems (acquired by Roche) and Applied Biosystems (now part of Thermo Fisher Scientific).
In 2007, Carl was recruited to join Gen-Probe as part of a board-directed succession plan for the CEO. Carl took over as CEO in 2009 and focused the strategy of the company to take advantage of its core molecular diagnostics and automation strengths.By introducing highly innovative molecular diagnostic systems and novel screening assays, the company extended its leadership position in a rapidly growing segment of diagnostics.Gen-Probe was sold to Hologic in 2012.
Carl holds a BA from The Johns Hopkins University and an MBA from the University of Chicago.